OAC
TPTX

OMERS Administration Corp’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

OMERS Administration Corp’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-393,200
Closed -$29.6M – 452
2022
Q2 		$29.6M Buy
+393,200
New +$17.5M 0.43% 51

OMERS Administration Corp's TPTX Position: Q3 2022 in Review

OMERS Administration Corp sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 393,200 shares — an estimated $29.6M sold.

OMERS Administration Corp first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $29.6M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • OMERS Administration Corp reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • OMERS Administration Corp sold 393,200 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $29.6M.
  • OMERS Administration Corp first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • OMERS Administration Corp's Turning Point Therapeutics, Inc. Common Stock position peaked at $29.6M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on OMERS Administration Corp's 13F filing for Q3 2022, filed 14 Nov 2022.